NCT01934933View on ClinicalTrials.gov

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 24, 2014

Primary Completion Date

September 23, 2015

Study Completion Date

January 30, 2017

Conditions

Ankylosing Spondylitis

Interventions

DRUG

celebrex

DRUG

Enbrel

DRUG

Enbrel plus Celebrex

Trial Locations (1)

510630

Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT01934933 - Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter